Cbderma Technology
Develops a transdermal CBD gel for potential cosmeceutical, pharmaceutical and pain-relief applications
Highlights
- New on EvolcAdded 2026-11-14
About Cbderma Technology
CBDerma develops CBD100, a cannabidiol gel using Futura Medical’s DermaSys technology to address stability and delivery through the skin. Laboratory work on human epidermis examined the penetration of cannabidiol.
The company is exploring commercialisation options for CBD100 with joint-venture partner Futura Medical. Potential applications range from cosmeceutical products to pharmaceutical dermal and pain-relief treatments.
CBDerma Technology Limited was founded in 2019 and is headquartered in Bristol, United Kingdom.
Product: CBD100, a transdermal cannabidiol gel developed using DermaSys technology.
Jobs at Cbderma Technology
Leadership
- Anthony Parker · Chief Executive OfficerSource: company website
More biotech & pharma companies
Celbius
Green chemistry R&D and natural-material development for businesses, research teams and specialist partnersNew on EvolcCellcentric
Develops an oral cancer drug for people with multiple myeloma and other cancersCellcraft
AI bioprocess control software, sensors and cell lines for biomanufacturers and bioprocess researchersCelleron Therapeutics
Develops precision cancer drugs and vaccines for patients with advanced, treatment-resistant cancersNew on EvolcCellestial Health
Preclinical small-molecule therapies targeting astrocytic networks for Parkinson’s and other neurological diseasesYoung companyNew on EvolcCellexus International
Single-use airlift bioreactors and related services for life-sciences and pharmaceutical organisationsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
- Response headerx-powered-by
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.